Effective and Innovative New Treatment Options for Tennis Elbow Sufferers

Several years ago a new high-energy shockwave treatment received FDA approval for the treatment of chronic tennis elbow nonresponsive to conservative treatment. This came after a period of clinical trials we performed. This outpatient shockwave therapy is an outpatient procedure known as OssaTron Treatment. Unfortunately, few insurance companies include the treatment in their plan and limited OssaTron facilities make it more difficult to arrange than other treatments proving just as effective.

Most recently, autologous blood injections for the treatment of refractory lateral epicondylitis was introduced and is proving a very effective, less invasive treatment option for chronic tennis elbow. The injection provides the necessary cellular and humoral mediators to promote healing.

The autologous blood is drawn from the dorsal vein of the hand and injected along the supracondylar ridge, into the undersurface of the extensor carpi radialis.

And a new procedure known as Percutaneous Tenotomy (Tenex) is a minimally invasive procedure which uses ultrasound imaging and patented TX MicroTip® technology to treat chronic tennis elbow unresponsive to other conservative treatment.

Chronic tennis elbow sufferers remaining symptomatic despite less invasive treatment programs may require a Lateral Epicondyle Release, an outpatient procedure designed to relieve the tension from the extensor tendon at the elbow joint.

Previous Post
Tennis Elbow, A Condition Affecting More than Those on the Court
Next Post
The 71st Annual Meeting of the American Society for Surgery of the Hand (ASSH).